A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials

Not Applicable

• Conditions: -B169 Acute hepatitis B without delta-agent and without hepatic coma; Acute hepatitis B without delta-agent and without hepatic coma; B169

• Registration Number: PER-044-03
• Lead Sponsor: BRISTOL MYERS SQUIBB COMPANY,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2003-08-13
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All subjects who participated in the phase III studies of Entecavir AI463022, AI463023, AI463026 and AI463027.

Exclusion Criteria

it is not relevant

Study & Design

• Study Type: Interventional
• Study Design: Not specified